Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brest Cancer × eribulin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 108 Triple Negative Breast Neoplasms 24 Neoplasm Metastasis 17 Sarcoma 15 Neoplasms 15 Ovarian Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Brain Neoplasms 5 Prostatic Neoplasms 4 Urinary Bladder Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3 Liposarcoma 3 Inflammatory Breast Neoplasms 3 Carcinoma, Transitional Cell 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Lymphoma 2 Leiomyosarcoma 2 HER2-negative Breast Cancer 2 Colorectal Neoplasms 2 Carcinoma 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Salivary Gland Neoplasms 1

Interventions

eribulin 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07333937 2026-01-12

NETHER

Xijing Hospital

Phase 2 Not yet recruiting

Brest Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡